---
title: "U.S. Stock Movement | Intuitive Surgical surged over 16% with Q3 revenue growth of 23%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262264031.md"
description: "On Wednesday, Intuitive Surgical surged over 16%, closing at $537.86. The financial report showed that Intuitive Surgical's revenue for the third quarter reached $2.51 billion, a 23% increase from $2.04 billion in the third quarter of 2024; GAAP net profit was $704 million, with diluted earnings per share of $1.95, compared to $565 million and $1.56 in the same period last year; non-GAAP net profit was $867 million, with diluted earnings per share of $2.40, compared to $669 million and $1.84 in the same period last year. Looking ahead, the company expects a global growth rate of approximately 17% to 17.5% for da Vinci surgical system procedures in 2025, compared to 17% in 2024; the non-GAAP gross margin is expected to be between 67% and 67.5% of revenue, compared to 69.1% in 2024, with this range including approximately 0.7% revenue impact from tariffs (fluctuating by 10 basis points); the non-GAAP operating expense growth rate is expected to be between 11% and 13%, compared to 10% in 2024"
datetime: "2025-10-22T13:45:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262264031.md)
  - [en](https://longbridge.com/en/news/262264031.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262264031.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262264031.md) | [繁體中文](https://longbridge.com/zh-HK/news/262264031.md)


# U.S. Stock Movement | Intuitive Surgical surged over 16% with Q3 revenue growth of 23%

According to Zhitong Finance APP, on Wednesday, Intuitive Surgical (ISRG.US) surged over 16%, closing at $537.86. The financial report shows that Intuitive Surgical's revenue for the third quarter reached $2.51 billion, a 23% increase from $2.04 billion in the third quarter of 2024; GAAP net profit was $704 million, with diluted earnings per share of $1.95, compared to $565 million and $1.56 in the same period last year; non-GAAP net profit was $867 million, with diluted earnings per share of $2.40, compared to $669 million and $1.84 in the same period last year.

Looking ahead, the company expects a global growth rate of approximately 17% to 17.5% in the number of da Vinci surgical system procedures for the full year of 2025, compared to 17% in 2024; the non-GAAP gross margin is expected to be between 67% and 67.5% of revenue, compared to 69.1% in 2024, with this range including approximately 0.7% revenue impact from tariffs (fluctuating by 10 basis points); the non-GAAP operating expense growth rate is expected to be between 11% and 13%, compared to 10% in 2024

### Related Stocks

- [Intuitive Surgical, Inc. (ISRG.US)](https://longbridge.com/en/quote/ISRG.US.md)

## Related News & Research

- [Heirloom Wealth Management Buys 16,650 Shares of Intuitive Surgical, Inc. $ISRG](https://longbridge.com/en/news/281345776.md)
- [If You Invested $1000 In Intuitive Surgical Stock 10 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/281215785.md)
- [Fragrant Prosperity Signals Deal Readiness With Solid Cash Position and AI-Fintech Focus](https://longbridge.com/en/news/281324452.md)
- [Kanzhun Ltd. Class A (2076) Gets a Buy from Guotai Haitong](https://longbridge.com/en/news/281135233.md)
- [Why Nvidia And Tesla Are Suddenly Knocking On Samsung's Door](https://longbridge.com/en/news/280999748.md)